Alcohol Abstinence Does Not Fully Reverse Abnormalities of Mucosal-Associated Invariant T Cells in the Blood of Patients With Alcoholic Hepatitis.


Journal

Clinical and translational gastroenterology
ISSN: 2155-384X
Titre abrégé: Clin Transl Gastroenterol
Pays: United States
ID NLM: 101532142

Informations de publication

Date de publication:
06 2019
Historique:
pubmed: 19 6 2019
medline: 25 9 2020
entrez: 19 6 2019
Statut: ppublish

Résumé

Alcoholic hepatitis (AH) develops in approximately 30% of chronic heavy drinkers. The immune system of patients with AH is hyperactivated, yet ineffective against infectious diseases. Mucosal-associated invariant T (MAIT) cells are innate-like lymphocytes that are highly enriched in liver, mucosa, and peripheral blood and contribute to antimicrobial immunity. We aimed to determine whether MAIT cells were dysregulated in heavy drinkers with and without AH and the effects of alcohol abstinence on MAIT cell recovery. MR1 tetramers loaded with a potent MAIT cell ligand 5-(2-oxopropylideneamino)-6-d-ribitylaminouracil were used in multiparameter flow cytometry to analyze peripheral blood MAIT cells in 59 healthy controls (HC), 56 patients with AH, and 45 heavy drinkers without overt liver disease (HDC) at baseline and 6- and 12-month follow-ups. Multiplex immunoassays were used to quantify plasma levels of cytokines related to MAIT cell activation. Kinetic Turbidimetric Limulus Amebocyte Lysate Assay and ELISA were performed to measure circulating levels of 2 surrogate markers for bacterial translocation (lipopolysaccharide and CD14), respectively. At baseline, patients with AH had a significantly lower frequency of MAIT cells than HDC and HC. HDC also had less MAIT cells than HC (median 0.16% in AH, 0.56% in HDC, and 1.25% in HC). Further, the residual MAIT cells in patients with AH expressed higher levels of activation markers (CD69, CD38, and human leukocyte antigen [HLA]-DR), the effector molecule granzyme B, and the immune exhaustion molecule PD-1. Plasma levels of lipopolysaccharide and CD14 and several cytokines related to MAIT cell activation were elevated in patients with AH (interferon [IFN]-α, interleukin [IL]-7, IL-15, IL-17, IL-18, IL-23, IFN-γ, and tumor necrosis factor α). Decreased MAIT cell frequency and upregulated CD38, CD69, and HLA-DR correlated negatively and positively, respectively, with aspartate aminotransferase level. MAIT cell frequency negatively correlated with IL-18. HLA-DR and CD38 levels correlated with several cytokines. At follow-ups, abstinent patients with AH had increased MAIT cell frequency and decreased MAIT cell activation. However, MAIT cell frequency was not fully normalized in patients with AH (median 0.31%). We showed that HDC had a reduction of blood MAIT cells despite showing little evidence of immune activation, whereas patients with AH had a severe depletion of blood MAIT cells and the residual cells were highly activated. Alcohol abstinence partially reversed those abnormalities.

Identifiants

pubmed: 31211759
doi: 10.14309/ctg.0000000000000052
pmc: PMC6613857
doi:

Substances chimiques

Biomarkers 0
Cytokines 0
HLA-DR Antigens 0
Interleukin-18 0

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

e00052

Subventions

Organisme : NCATS NIH HHS
ID : UL1 TR002649
Pays : United States
Organisme : NIAAA NIH HHS
ID : R01 AA021171
Pays : United States
Organisme : NIAAA NIH HHS
ID : U01 AA021840
Pays : United States
Organisme : NIAAA NIH HHS
ID : R37 AA021171
Pays : United States
Organisme : NIAAA NIH HHS
ID : UH2 AA026218
Pays : United States

Références

J Exp Med. 1999 Jun 21;189(12):1907-21
pubmed: 10377186
Hepatology. 2009 Aug;50(2):638-44
pubmed: 19575462
Hepatology. 2010 Jan;51(1):307-28
pubmed: 20034030
Blood. 2011 Jan 27;117(4):1250-9
pubmed: 21084709
Am J Physiol Gastrointest Liver Physiol. 2011 Apr;300(4):G516-25
pubmed: 21252049
World J Hepatol. 2011 May 27;3(5):114-7
pubmed: 21731903
Arthritis Rheum. 2012 Jan;64(1):153-61
pubmed: 21904999
Gastroenterology. 2011 Nov;141(5):1572-85
pubmed: 21920463
Am J Physiol Gastrointest Liver Physiol. 2012 May 1;302(9):G966-78
pubmed: 22241860
Clin Exp Immunol. 2012 Sep;169(3):302-10
pubmed: 22861370
Blood. 2013 Jan 24;121(4):614-23
pubmed: 23223428
Blood. 2013 Feb 14;121(7):1124-35
pubmed: 23243281
Blood. 2013 Feb 7;121(6):951-61
pubmed: 23255555
J Immunol. 2013 Apr 1;190(7):3142-52
pubmed: 23447689
Eur J Immunol. 2014 Jan;44(1):195-203
pubmed: 24019201
J Exp Med. 2013 Oct 21;210(11):2305-20
pubmed: 24101382
Nature. 2014 May 15;509(7500):361-5
pubmed: 24695216
World J Gastroenterol. 2014 May 28;20(20):6279-86
pubmed: 24876748
Proc Natl Acad Sci U S A. 2014 Oct 21;111(42):E4485-93
pubmed: 25288760
Gastroenterology. 2015 Mar;148(3):590-602.e10
pubmed: 25479137
Mucosal Immunol. 2016 Mar;9(2):401-13
pubmed: 26220166
PLoS Pathog. 2015 Aug 21;11(8):e1005072
pubmed: 26295709
J Biol Chem. 2015 Dec 18;290(51):30204-11
pubmed: 26468291
Biomolecules. 2015 Oct 15;5(4):2573-88
pubmed: 26501334
World J Gastroenterol. 2015 Nov 14;21(42):11904-13
pubmed: 26576079
Alcohol Res. 2015;37(2):185-97
pubmed: 26695744
Alcohol Res. 2015;37(2):237-50
pubmed: 26695748
J Infect. 2016 Mar;72(3):338-52
pubmed: 26724769
J Hepatol. 2016 May;64(5):1118-1127
pubmed: 26743076
Eur J Immunol. 2016 Sep;46(9):2204-10
pubmed: 27296288
Clin Gastroenterol Hepatol. 2016 Dec;14(12):1831-1838.e3
pubmed: 27320325
JCI Insight. 2016 Jun 2;1(8):null
pubmed: 27331143
Nat Commun. 2016 Jun 23;7:11653
pubmed: 27337592
J Clin Transl Hepatol. 2016 Jun 28;4(2):113-22
pubmed: 27350941
Clin Liver Dis. 2016 Aug;20(3):595-606
pubmed: 27373619
PLoS One. 2016 Jul 14;11(7):e0159243
pubmed: 27416100
Proc Natl Acad Sci U S A. 2016 Sep 6;113(36):10133-8
pubmed: 27543331
Clin Transl Immunology. 2016 Aug 19;5(8):e98
pubmed: 27588203
Immunology. 2017 Jan;150(1):45-54
pubmed: 27633333
Hepatology. 2017 Aug;66(2):575-590
pubmed: 28466561
World J Hepatol. 2017 Apr 28;9(12):567-585
pubmed: 28515843
Sci Rep. 2017 Jun 30;7(1):4462
pubmed: 28667254
Hepatology. 2018 Apr;67(4):1284-1302
pubmed: 29083504
Gut. 2018 May;67(5):918-930
pubmed: 29097439
Hepatology. 2018 Jul;68(1):172-186
pubmed: 29328499
Semin Liver Dis. 2018 Feb;38(1):60-65
pubmed: 29471566
Front Immunol. 2018 Mar 19;9:472
pubmed: 29616020
Immunol Cell Biol. 2018 Jul;96(6):573-587
pubmed: 29656544
Nat Commun. 2018 Jun 1;9(1):2146
pubmed: 29858567

Auteurs

Wei Li (W)

Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, Indiana, USA.

Edward L Lin (EL)

Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, Indiana, USA.

Suthat Liangpunsakul (S)

Division of Gastroenterology and Hepatology, Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Roudebush Veterans Administration Medical Center, Indianapolis, Indiana, USA.
Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, Indiana, USA.

Jie Lan (J)

Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, Indiana, USA.

Sai Chalasani (S)

Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, Indiana, USA.

Sushmita Rane (S)

Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, Indiana, USA.

Puneet Puri (P)

Division of Gastroenterology and Hepatology, Department of Medicine, Virginia Commonwealth University, Richmond, Virginia, USA.

Patrick S Kamath (PS)

Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.

Arun J Sanyal (AJ)

Division of Gastroenterology and Hepatology, Department of Medicine, Virginia Commonwealth University, Richmond, Virginia, USA.

Vijay H Shah (VH)

Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.

Svetlana Radaeva (S)

National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Rockville, Maryland, USA.

David W Crabb (DW)

Division of Gastroenterology and Hepatology, Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Internal Medicine, Eskenazi Health, Indianapolis, Indiana, USA.

Naga Chalasani (N)

Division of Gastroenterology and Hepatology, Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA.

Qigui Yu (Q)

Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, Indiana, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH